Hearts and bones

Nutrition, Metabolism and Cardiovascular Diseases

Volumn 13, Issue 3, 2003, Pages 165-174

  Qi, L ^a   Shen, H ^a   Ordovas, J M ^a  

^a TUFTS UNIVERSITY   (United States)

Author keywords

Aging; Cardiovascular diseases; Genetic polymorphisms; Lipoproteins; Nutrition; Transcription factors

Indexed keywords

CALCIUM; FOLIC ACID; LIPID; SEX HORMONE;

BONE; BONE DISEASE; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; CORRELATION ANALYSIS; DIETARY INTAKE; GENETIC CODE; HEART; HEREDITY; HUMAN; NUTRIENT MANAGEMENT; OSTEOPOROSIS; REVIEW; RISK ASSESSMENT;

EID: 2342436689     PISSN: 09394753     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0939-4753(03)80176-X     Document Type: Note

References (110)

1. Barengolts EI, Berman M, Kukreja SC, Kouznetsova T, Lin C, Chomka EV (1998) Osteoporosis and coronary atherosclerosis in asymptomatic postmenopausal women. Calcif Tissue Int 62: 209-213
2. Frye MA, Melton LJ, III, Bryant SC, Fitzpatrick LA, Wahner HW, Schwartz RS, et al (1992) Osteoporosis and calcification of the aorta. Bone Miner 19: 185-194
3. Willett WC (2002) Balancing life-style and genomics research for disease prevention. Science 296: 695-698
4. Hegsted DM (1986) Calcium and osteoporosis. J Nutr 116: 2316-2319
5. Laroche M, Pouilles JM, Ribot C, Bendayan P, Bernard J, Boccalon H, et al (1994) Comparison of the bone mineral content of the lower limbs in men with ischaemic atherosclerotic disease. Clin Rheumatol 13: 611-614
6. Ramsey-Goldman R, Manzi S (2001) Association of osteoporosis and cardiovascular disease in women with systemic lupus erythematosus. Arthritis Rheum. 44: 2338-2341
7. Uyama O, Yoshimoto Y, Yamamoto Y, Kawai A (1997) Bone changes and carotid atherosclerosis in postmenopausal women. Stroke 28: 1730-1732
8. Jie KG, Bots ML, Vermeer C, Witteman JC, Grobbee DE (1996) Vitamin K status and bone mass in women with and without aortic atherosclerosis: a population-based study. Calcif. Tissue Int. 59: 352-356
9. Camper-Kirby D, Welch S, Walker A, Shiraishi I, Setchell KD, Schaefer E, et al (2001) Myocardial Akt activation and gender: increased nuclear activity in females versus males. Circ Res 88: 1020-1027
10. Lee ZH, Lee SE, Kim CW, Lee SH, Kim SW, Kwack K, et al (2002) IL-1alpha stimulation of osteoclast survival through the PI 3-kinase/Akt and ERK pathways. J Biochem (Tokyo) 131: 161-166
11. Wong ND, Hsu JC, Detrano RC, Diamond G, Eisenberg H, Gardin JM (2000) Coronary artery calcium evaluation by electron beam computed tomography and its relation to new cardiovascular events. Am J Cardiol 86: 495-498
12. Bostrom K, Watson KE, Horn S, Wortham C, Herman IM, Demer LL (1993) Bone morphogenetic protein expression in human atherosclerotic lesions. J Clin Invest 91: 1800-1809
13. Giachelli CM, Bae N, Almeida M, Denhardt DT, Alpers CE, Schwartz SM (1993) Osteopontin is elevated during neointima formation in rat arteries and is a novel component of human atherosclerotic plaques. J Clin Invest 92: 1686-1696
14. Hofbauer LC, Shui C, Riggs BL, Dunstan CR, Spelsberg TC, O'Brien T, et al (2001) Effects of immunosuppressants on receptor activator of NF-kappaB ligand and osteoprotegerin production by human osteoblastic and coronary artery smooth muscle cells. Biochem Biophys Res Commun 280: 334-339
15. Skoog I, Kalaria RN, Breteler MM (1999) Vascular factors and Alzheimer disease. Alzheimer Dis Assoc Disord 13 (Suppl 3): S106-S114
16. Weller II (2000) The relation between hip fracture and Alzheimer's disease in the Ccanadian national population health survey health institutions data, 1994-1995. A cross-sectional study. Ann Epidemiol 10: 461.
17. Drake TA, Schadt E, Hannani K, Kabo JM, Krass K, Colinayo V, et al (2001) Genetic loci determining bone density in mice with diet-induced atherosclerosis. Physiol Genomics 5: 205-215
18. Kornman KS, Duff GW (2001) Candidate genes as potential links between periodontal and cardiovascular diseases. Ann Periodontol 6: 48-57
19. Mahley RW, Rall SC, Jr. (2000) Apolipoprotein E: far more than a lipid transport protein. Annu Rev Genomics Hum Genet 1: 507-537
20. Gerdes LU, Vestergaard P, Hermann AP, Mosekilde L (2001) Regional and hormone-dependent effects of apolipoprotein E genotype on changes in bone mineral in perimenopausal women. J Bone Miner Res 16: 1906-1916
21. Johnston JM, Cauley JA, Ganguli M (1999) APOE 4 and hip fracture risk in a community-based study of older adults. J Am Geriatr Soc 47: 1342-1345
22. Cauley JA, Zmuda JM, Yaffe K, Kuller LH, Ferrell RE, Wisniewski SR, et al (1999) Apolipoprotein E polymorphism: A new genetic marker of hip fracture risk - The Study of Osteoporotic Fractures. J Bone Miner Res 14: 1175-1181
23. Ciaraldi TP, Cha BS, Park KS, Carter L, Mudaliar SR, Henry RR (2002) Free fatty acid metabolism in human skeletal muscle is regulated by PPARgamma and RXR agonists. Ann NY Acad Sci 967: 66-70
24. Bocher V, Pineda-Torra I, Fruchart JC, Staels B (2002) PPARs: transcription factors controlling lipid and lipoprotein metabolism. Ann NY Acad Sci 967: 7-18
25. Swarbrick MM, Chapman CM, McQuillan BM, Hung J, Thompson PL, Beilby JP (2001) A Pro12Ala polymorphism in the human peroxisome proliferator-activated receptor-gamma 2 is associated with combined hyperlipidaemia in obesity. Eur J Endocrinol 144: 277-282
26. Wang XL, Oosterhof J, Duarte N (1999) Peroxisome proliferator-activated receptor gamma C161→T polymorphism and coronary artery disease. Cardiovasc Res 44: 588-594
27. Ogawa S, Urano T, Hosoi T, Miyao M, Hoshino S, Fujita M, et al (1999) Association of bone mineral density with a polymorphism of the peroxisome proliferator-activated receptor gamma gene: PPARgamma expression in osteoblasts. Biochem Biophys Res Commun 260: 122-126
28. Parhami F, Tintut Y, Beamer WG, Gharavi N, Goodman W, Demer LL (2001) Atherogenic high-fat diet reduces bone mineralization in mice. J Bone Miner Res 16: 182-188
29. Wohl GR, Loehrke L, Watkins BA, Zernicke RF (1998) Effects of high-fat diet on mature bone mineral content, structure, and mechanical properties. Calcif Tissue Int 63: 74-79
30. Parhami F, Jackson SM, Tintut Y, Le V, Balucan JP, Territo M, et al (1999) Atherogenic diet and minimally oxidized low density lipoprotein inhibit osteogenic and promote adipogenic differentiation of marrow stromal cells. J Bone Miner Res 14: 2067-2078
31. Parhami F, Morrow AD, Balucan J, Leitinger N, Watson AD, Tintut Y, et al (1997) Lipid oxidation products have opposite effects on calcifying vascular cell and bone cell differentiation. A possible explanation for the paradox of arterial calcification in osteoporotic patients. Arterioscler Thromb Vasc Biol 17: 680-687
32. Yamaguchi T, Sugimoto T, Yano S, Yamauchi M, Sowa H, Chen Q, et al (2002) Plasma lipids and osteoporosis in postmenopausal women. Endocrinol J 49: 211-217
33. Edwards CJ, Hart DJ, Spector TD (2000) Oral statins and increased bone-mineral density in postmenopausal women. Lancet 355: 2218-2219
34. Chan KA, Andrade SE, Boles M, Buist DS, Chase GA, Donahue JG, et al (2000) Inhibitors of hydroxymethylglutarylcoenzyme A reductase and risk of fracture among older women. Lancet 355: 2185-2188
35. Wang PS, Solomon DH, Mogun H, Avorn J (2000) HMG-CoA reductase inhibitors and the risk of hip fractures in elderly patients. JAMA 283: 3211-3216
36. Trichopoulou A, Georgiou E, Bassiakos Y, Lipworth L, Lagiou P, Proukakis C, et al (2000) Energy intake and monounsaturated fat in relation to bone mineral density among women and men in Greece. Prev Med 26: 395-400
37. Albertazzi P, Coupland K (2002) Polyunsaturated fatty acids. Is there a role in postmenopausal osteoporosis prevention? Maturitas 42: 13-22
38. Hu FB, Manson JE, Willett WC (2001) Types of dietary fat and risk of coronary heart disease: a critical review. J Am Coll Nutr 20: 5-19
39. Watkins BA, Li Y, Allen KG, Hoffmann WE, Seifert MF (2000) Dietary ratio of (n-6)/(n-3) polyunsaturated fatty acids alters the fatty acid composition of bone compartments and biomarkers of bone formation in rats. J Nutr 130: 2274-2284
40. Watkins BA, Shen CL, Allen KG, Seifert MF (1996) Dietary (n-3) and (n-6) polyunsaturates and acetylsalicylic acid alter ex vivo PGE2 biosynthesis, tissue IGF-I levels, and bone morphometry in chicks. J Bone Miner Res 11: 1321-1332
41. Sakaguchi K, Morita I, Murota S (1994) Eicosapentaenoic acid inhibits bone loss due to ovariectomy in rats. Prostaglandins Leukot. Essent. Fatty Acids 50: 81-84
42. Moon J, Bandy B, Davison AJ (1992) Hypothesis: etiology of atherosclerosis and osteoporosis: are imbalances in the calciferol endocrine system implicated? J Am Coll Nutr 11: 567-583
43. Doherty TM, Detrano RC (1994) Coronary arterial calcification as an active process: a new perspective on an old problem. Calcif Tissue Int 54: 224-230
44. Gennari L, Becherini L, Falchetti A, Masi L, Massart F, Brandi ML (2002) Genetics of osteoporosis: role of steroid hormone receptor gene polymorphisms. J Steroid Biochem Mol Biol 81: 1-24
45. Ortlepp JR, Lauscher J, Hoffmann R, Hanrath P, Joost HG (2001) The vitamin D receptor gene variant is associated with the prevalence of type 2 diabetes mellitus and coronary artery disease. Diabet Med 18: 842-845
46. Ortlepp JR, Hoffmann R, Ohme F, Lauscher J, Bleckmann F, Hanrath P (2001) The vitamin D receptor genotype predisposes to the development of calcific aortic valve stenosis. Heart 85: 635-638
47. Van Schooten FJ, Hirvonen A, Maas LM, De Mol BA, Kleinjans JC, Bell DA, et al (1998) Putative susceptibility markers of coronary artery disease: association between VDR genotype, smoking, and aromatic DNA adduct levels in human right atrial tissue. FASEB J 12: 1409-1417
48. Nakano Y, Oshima T, Sasaki S, Yamaoka K, Matsumoto T, Hirao H, et al (2000) Vitamin D receptor gene polymorphism is associated with serum total and ionized calcium concentration. J Mol Med 78: 575-579
49. Tsukamoto K, Orimo H, Hosoi T, Miyao M, Yoshida H, Watanabe S, et al (2000) Association of bone mineral density with polymorphism of the human matrix Gla protein locus in elderly women. J. Bone Miner Metab 18: 27-30
50. Herrmann SM, Whatling C, Brand E, Nicaud V, Gariepy J, Simon A, et al (2000) Polymorphisms of the human matrix gla protein (MGP) gene, vascular calcification, and myocardial infarction. Arterioscler Thromb Vasc Biol 20: 2386-2393
51. Brandstrom H, Stiger F, Lind L, Kahan T, Melhus H, Kindmark A (2002) A single nucleotide polymorphism in the promoter region of the human gene for osteoprotegerin is related to vascular morphology and function. Biochem Biophys Res Commun 293: 13-17
52. Simonet WS, Lacey DL, Dunstan CR, Kelley M, Chang MS, Luthy R et al (1997) Osteoprotegerin: a novel secreted protein involved in the regulation of bone density. Cell 89: 309-319.
53. Arko B, Prezelj J, Komel R, Kocijancic A, Hudler P, Marc J. (2002) Sequence variations in the osteoprotegerin gene promoter in patients with postmenopausal osteoporosis. J Clin Endocrinol Metab 87: 4080-4084
54. Langdahl BL, Carstens M, Stenkjaer L, Eriksen EF (2002) Polymorphisms in the osteoprotegerin gene are associated with osteoporotic fractures. J Bone Miner Res 17: 1245-1255
55. Hofbauer LC, Schoppet M (2001) Osteoprotegerin: a link between osteoporosis and arterial calcification? Lancet 358: 257-259
56. Arad Y, Spadaro LA, Roth M, Scordo J, Goodman K, Sherman S, et al (1998) Serum concentration of calcium, 1,25 vitamin D and parathyroid hormone are not correlated with coronary calcifications. An electron beam computed tomography study. Coron Artery Dis 9: 513-518
57. Watson KE, Abrolat ML, Malone LL, Hoeg JM, Doherty T, Detrano R, et al (1997) Active serum vitamin D levels are inversely correlated with coronary calcification. Circulation 96: 1755-1760
58. Bennani-Kabchi N, Kehel L, El Bouayadi F, Fdhil H, Amarti A, Saidi A et al (2000) New model of atherosclerosis in insulin resistant sand rats: hypercholesterolemia combined with D2 vitamin. Atherosclerosis 150: 55-61
59. Holzgreve H, Burkle B. (1993) Anti-atherosclerotic effects of calcium antagonists. J Hypertens (Suppl) 11: S55-S59
60. Morikawa Y, Nakagawa H, Okayama A, Mikawa K, Sakata K, Miura K, et al (2002) A cross-sectional study on association of calcium intake with blood pressure in Japanese population. J Hum Hypertens 16: 105-110
61. Heaney RP, Davies KM, Barger-Lux MJ (2002) Calcium and weight: clinical studies. J Am Coll Nutr 21: 152S-155S
62. Mudd SH, Skovby F, Levy HL, Pettigrew KD, Wilcken B, Pyeritz RE, et al (1985) The natural history of homocystinuria due to cystathionine beta-synthase deficiency. Am J Hum Genet 37: 1-31
63. Woo KS, Chook P, Lolin YI, Cheung AS, Chan LT, Sun YY, et al (1997) Hyperhomocyst(e)inemia is a risk factor for arterial endothelial dysfunction in humans. Circulation 96: 2542-2544
64. Harpel PC, Zhang X, Borth W. (1996) Homocysteine and hemostasis: pathogenic mechanisms predisposing to thrombosis. J Nutr 126: 1285S-1289S
65. Whiting SJ, Draper HH (1981) Effect of a chronic acid load as sulfate or sulfur amino acids on bone metabolism in adult rats. J Nutr 111: 1721-1726
66. Khan M, Yamauchi M, Srisawasdi S, Stiner D, Doty S, Paschalis EP, et al (2001) Homocysteine decreases chondrocyte-mediated matrix mineralization in differentiating chick limb-bud mesenchymal cell micro-mass cultures. Bone 28: 387-398
67. Doshi SN, McDowell IF, Moat SJ, Lang D, Newcombe RG, Kredan MB, et al (2001) Folate improves endothelial function in coronary artery disease: an effect mediated by reduction of intracellular superoxide? Arterioscler Thromb Vasc Biol 21: 1196-1202
68. Villa ML, Marcus R, Ramirez DR, Kelsey JL (1995) Factors contributing to skeletal health of postmenopausal Mexican-American women. J Bone Miner Res 10: 1233-1242
69. Lumbers M, New SA, Gibson S, Murphy MC (2001) Nutritional status in elderly female hip fracture patients: comparison with an age-matched home living group attending day centres. Br J Nutr 85: 733-740
70. Andreassi MG, Botto N, Cocci F, Battaglia D, Antonioli E, Masetti S, et al (2003) Methylenetetrahydrofolate reductase gene C677T polymorphism, homocysteine, vitamin B12, and DNA damage in coronary artery disease. Hum Genet 112: 171-177
71. Miyao M, Morita H, Hosoi T, Kurihara H, Inoue S, Hoshino S, et al (2000) Association of methylenetetrahydrofolate reductase (MTHFR) polymorphism with bone mineral density in post-menopausal Japanese women. Calcif Tissue Int 66: 190-194
72. Lubec B, Fang-Kircher S, Lubec T, Blom HJ, Boers GH (1996) Evidence for McKusick's hypothesis of deficient collagen cross-linking in patients with homocystinuria. Biochim Biophys Acta 1315: 159-162
73. Damien E, Price JS, Lanyon LE (2000) Mechanical strain stimulates osteoblast proliferation through the estrogen receptor in males as well as females. J Bone Miner Res 15: 2169-2177
74. Fohr B, Schulz A, Battmann A (2000) Sex steroids and bone metabolism: comparison of in vitro effects of 17beta-estradiol and testosterone on human osteosarcoma cell lines of various gender and differentiation. Exp Clin Endocrinol Diabetes 108: 414-423
75. Green A, Bain C (1993) Epidemiological overview of oestrogen replacement and cardiovascular disease. Baillieres Clin Endocrinol Metab 7: 95-112
76. Sullivan ML, Martinez CM, Gennis P, Gallagher EJ (1998) The cardiac toxicity of anabolic steroids. Prog Cardiovasc Dis 41: 1-15
77. Kobayashi N, Fujino T, Shirogane T, Furuta I, Kobamatsu Y, Yaegashi M, et al (2002) Estrogen receptor alpha polymorphism as a genetic marker for bone loss, vertebral fractures and susceptibility to estrogen. Maturitas 41: 193-201
78. Sapir-Koren R, Livshits G, Landsman T, Kobyliansky E (2001) Bone mineral density is associated with estrogen receptor gene polymorphism in men. Anthropol Anz 59: 343-353
79. Lu H, Higashikata T, Inazu A, Nohara A, Yu W, Shimizu M, et al (2002) Association of estrogen receptor-alpha gene polymorphisms with coronary artery disease in patients with familial hypercholesterolemia. Arterioscler Thromb Vasc Biol 22: 817-823
80. Zitzmann M, Brune M, Kornmann B, Gromoll J, Junker R, Nieschlag E (2001) The CAG repeat polymorphism in the androgen receptor gene affects bone density and bone metabolism in healthy males. Clin Endocrinol (Oxf) 55: 649-657
81. Zitzmann M, Brune M, Kornmann B, Gromoll J, von Eckardstein S, von Eckardstein A et al (2001) The CAG repeat polymorphism in the AR gene affects high density lipoprotein cholesterol and arterial vasoreactivity. J Clin Endocrinol Metab 86: 4867-4873
82. Westberg L, Baghaei F, Rosmond R, Hellstrand M, Landen M, Jansson M, et al (2001) Polymorphisms of the androgen receptor gene and the estrogen receptor beta gene are associated with androgen levels in women. J Clin Endocrinol Metab 86: 2562-2568
83. Beilin J, Ball EM, Favaloro JM, Zajac JD (2000) Effect of the androgen receptor CAG repeat polymorphism on transcriptional activity: specificity in prostate and non-prostate cell lines. J Mol Endocrinol 25: 85-96
84. Kunnas TA, Laippala P, Penttila A, Lehtimaki T, Karhunen PJ (2000) Association of polymorphism of human alpha oestrogen receptor gene with coronary artery disease in men: a necropsy study. BMJ 321: 273-274
85. Fritz WA, Wang J, Eltoum IE, Lamartiniere CA (2002) Dietary genistein down-regulates androgen and estrogen receptor expression in the rat prostate. Mol Cell Endocrinol 186: 89-99
86. Cotroneo MS, Wang J, Eltoum IA, Lamartiniere CA (2001) Sex steroid receptor regulation by genistein in the prepubertal rat uterus. Mol Cell Endocrinol 173: 135-145
87. Greendale GA, FitzGerald G, Huang MH, Sternfeld B, Gold E, Seeman T, et al (2002) Dietary soy isoflavones and bone mineral density: results from the study of women's health across the nation. Am J Epidemiol 155: 746-754
88. Mei J, Yeung SS, Kung AW (2001) High dietary phytoestrogen intake is associated with higher bone mineral density in postmenopausal but not premenopausal women. J Clin Endocrinol Metab 86: 5217-5221
89. Dalais FS, Rice GE, Wahlqvist ML, Grehan M, Murkies AL, Medley G, et al (1998) Effects of dietary phytoestrogens in postmenopausal women. Climacteric 1: 124-129
90. Ishimi Y, Yoshida M, Wakimoto S, Wu J, Chiba H, Wang X, et al (2002) Genistein, a soybean isoflavone, affects bone marrow lymphopoiesis and prevents bone loss in castrated male mice. Bone 31: 180-185
91. Potter SM, Baum JA, Teng H, Stillman RJ, Shay NF, Erdman JW, Jr (1998) Soy protein and isoflavones: their effects on blood lipids and bone density in postmenopausal women. Am J Clin Nutr 68: 1375S-1379S
92. Somjen D, Amir-Zaltsman Y, Gayer B, Kulik T, Knoll E, Stern N, et al (2002) 6-Carboxymethyl genistein: a novel selective oestrogen receptor modulator (SERM) with unique, differential effects on the vasculature, bone and uterus. J Endocrinol 173: 415-427
93. Zhang X, Llamado L, Pillay I, Price P, Will R (2002) Interleukin-1 gene polymorphism disease activity and bone mineral metabolism in rheumatoid arthritis. Chin Med J (Engl.) 115: 46-49
94. Momiyama Y, Hirano R, Taniguchi H, Nakamura H, Ohsuzu F (2001) Effects of interleukin-1 gene polymorphisms on the development of coronary artery disease associated with Chlamydia pneumoniae infection. J Am Coll Cardiol 38: 712-717
95. Fontova R, Gutierrez C, Vendrell J, Broch M, Vendrell I, Simon I, et al (2002) Bone mineral mass is associated with interleukin 1 receptor autoantigen and TNF-alpha gene polymorphisms in post-menopausal Mediterranean women. J Endocrinol Invest 25: 684-690
96. Lin RC, Morris BJ (2002) Association analysis of polymorphisms at the interleukin-1 locus in essential hypertension. Am J Med Genet 107: 311-316
97. Murray RE, McGuigan F, Grant SF, Reid DM, Ralston SH (1997) Polymorphisms of the interleukin-6 gene are associated with bone mineral density. Bone 21: 89-92
98. Ota N, Nakajima T, Nakazawa I, Suzuki T, Hosoi T, Orimo H, et al (2001) A nucleotide variant in the promoter region of the interleukin-6 gene associated with decreased bone mineral density. J Hum Genet 46: 267-272
99. Basso F, Lowe GD, Rumley A, McMahon AD, Humphries SE (2002) Interleukin-6 -174G>C polymorphism and risk of coronary heart disease in West of Scotland coronary prevention study (WOSCOPS). Arterioscler Thromb Vasc Biol 22: 599-604
100. Humphries SE, Luong LA, Ogg MS, Hawe E, Miller GJ (2001) The interleukin-6 -174 G/C promoter polymorphism is associated with risk of coronary heart disease and systolic blood pressure in healthy men. Eur Heart J 22: 2243-2252
101. Ferrari SL, Garnero P, Emond S, Montgomery H, Humphries SE, Greenspan SL. (2001) A functional polymorphic variant in the interleukin-6 gene promoter associated with low bone resorption in postmenopausal women. Arthritis Rheum 44: 196-201
102. Cambien F, Ricard S, Troesch A, Mallet C, Generenaz L, Evans A, et al (1996) Polymorphisms of the transforming growth factor-beta 1 gene in relation to myocardial infarction and blood pressure. The Etude Cas-Temoin de l'Infarctus du Myocarde (ECTIM) Study. Hypertension 28: 881-887
103. Hinke V, Seek T, Clanget C, Scheidt-Nave C, Ziegler R, Pfeilschifter J (2001) Association of transforming growth factor-beta1 (TGFbeta 1) T29 → C gene polymorphism with bone mineral density (BMD), changes in BMD, and serum concentrations of TGF-beta 1 in a population-based sample of postmenopausal German women. Calcif Tissue Int 69: 315-320
104. Yamada Y, Fujisawa M, Ando F, Niino N, Tanaka M, Shimokata H (2002) Association of a polymorphism of the transforming growth factor-beta 1 gene with blood pressure in Japanese individuals. J Hum Genet 47: 243-248
105. Wennberg P, Nordstrom P, Lorentzon R, Lerner UH, Lorentzon M (2002) TNF-alpha gene polymorphism and plasma TNF-alpha levels are related to lumbar spine bone area in healthy female Caucasian adolescents. Eur J Endocrinol 146: 629-634
106. Padovani JC, Pazin-Filho A, Simoes MV, Marin-Neto JA, Zago MA, Franco RF (2000) Gene polymorphisms in the TNF locus and the risk of myocardial infarction. Thromb Res 100: 263-269
107. Cubrilo-Turek M, Sertic J, Durakovic Z (2001) Angiotensin-converting enzyme gene polymorphism, lipids, and apolipoproteins in menopausal women on hormone replacement therapy. Acta Med Croatica 55: 161-167
108. Woods D, Onambele G, Woledge R, Skelton D, Bruce S, Humphries SE, et al (2001) Angiotensin-I converting enzyme genotype-dependent benefit from hormone replacement therapy in isometric muscle strength and bone mineral density. J Clin Endocrinol Metab 86: 2200-2204
109. Yamada Y, Ando F, Niino N, Shimokata H (2002) Association of a polymorphism of the CC chemokine receptor-2 gene with bone mineral density. Genomics 80: 8-12
110. Valdes AM, Wolfe ML, O'Brien EJ, Spurr NK, Gefter W, Rut A, et al (2002) Val64Ile polymorphism in the C-C chemokine receptor 2 is associated with reduced coronary artery calcification. Arterioscler Thromb Vasc Biol 22: 1924-1928